Research Involving Children as Subjects and Not Otherwise Approvable by an Institutional Review Board: Process for Referrals to Food and Drug Administration and Office for Human Research Protections: Draft Guidance for Institutional Review Boards, Investigators, and Sponsors

Information

Type

Guidance

Regulated products

Biologics, Drugs, Medical Devices

Topics

Pediatric Product Development

Published

March 30, 2023

Last updated

April 11, 2024

Description

A draft guidance document outlines the process for referring research involving children to the FDA and OHRP, focusing on pediatric product development.

Organization

Country / Region

United States

License

Other (Public Domain)

Feedback

Suggest an improvement to this page

Actions

Social networks

Embed